Filing Details

Accession Number:
0001181431-11-009279
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-10 21:55:22
Reporting Period:
2011-02-08
Filing Date:
2011-02-10
Accepted Time:
2011-02-10 21:55:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306695 Sanderling Venture Partners Vi Co Investment Fund Lp C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1306717 Sanderling Venture Partners Vi Lp C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1429282 Partnership Limited Vi Sanderling C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1429283 Sanderling Vi Beteiligungs Gmbh & Co Kg C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
1429588 Vi Management Ventures Sanderling C/O Sanderling Ventures
400 South El Camino Real, Suite 1200
San Mateo CA 94402
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-08 736,583 $0.00 736,583 No 4 C Direct
Common Stock Acquisiton 2011-02-08 14,877 $0.00 14,877 No 4 C Direct
Common Stock Acquisiton 2011-02-08 24,871 $0.00 24,871 No 4 C Direct
Common Stock Acquisiton 2011-02-08 29,634 $0.00 29,634 No 4 C Direct
Common Stock Acquisiton 2011-02-08 681,715 $0.00 681,715 No 4 C Direct
Common Stock Acquisiton 2011-02-08 344,355 $0.00 344,355 No 4 C Direct
Common Stock Acquisiton 2011-02-08 12,058 $0.00 12,058 No 4 C Direct
Common Stock Acquisiton 2011-02-08 14,366 $0.00 14,366 No 4 C Direct
Common Stock Acquisiton 2011-02-08 341,788 $0.00 341,788 No 4 C Direct
Common Stock Acquisiton 2011-02-08 129,445 $0.00 129,445 No 4 C Direct
Common Stock Acquisiton 2011-02-08 4,533 $0.00 4,533 No 4 C Direct
Common Stock Acquisiton 2011-02-08 5,400 $0.00 5,400 No 4 C Direct
Common Stock Acquisiton 2011-02-08 128,479 $0.00 128,479 No 4 C Direct
Common Stock Acquisiton 2011-02-08 46,379 $7.00 46,379 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-08 736,583 $0.00 736,583 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-08 14,877 $0.00 14,877 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-08 24,871 $0.00 24,871 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-08 29,634 $0.00 29,634 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2011-02-08 681,715 $0.00 681,715 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 344,355 $0.00 344,355 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 12,058 $0.00 12,058 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 14,366 $0.00 14,366 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 341,788 $0.00 341,788 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 129,445 $0.00 129,445 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 4,533 $0.00 4,533 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 5,400 $0.00 5,400 $0.00
Common Stock Convertible Promissory Notes Disposition 2011-02-08 128,479 $0.00 128,479 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The securities are held by Sanderling Venture Partners VI, L.P.
  2. The securities are held by Sanderling Ventures Management VI.
  3. The securities are held by Sanderling VI Beteiligungs GmbH & Co. KG.
  4. The securities are held by Sanderling VI Limited Partnership.
  5. The Series A Convertible Preferred Stock had no expiration date and each share of Series A Convertible Preferred Stock was automatically converted into common stock on a 1-for-1 basis upon the consummation of the Issuer's initial public offering.
  6. The securities are held by Sanderling Venture Partners VI Co-Investment Fund.
  7. All principal and accrued interest on the Convertible Promissory Notes was automatically converted into shares of Common Stock upon the consummation of the Issuer's initial public offering.
  8. All principal on the Convertible Promissory Notes was automatically converted into shares of Common Stock upon the consummation of the Issuer's initial public offering at a conversion price equal to the per share price of the Common Stock sold in the Issuer's initial public offering.